Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Jan 20, 2023 11:18am
RE:RE:RE:RE:Time to cool it.
"Dead money" as you call it has turned out to be a good thing for me. Having lived the ride from 20 cents, to over 2 bucks, then losing 50% from its high, and seeing what the market
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 20, 2023 9:51am
RE:RE:RE:Time to cool it.
Because it's dead money while you're waiting around. Opportunity cost. Plus you know this stock has insane swings so why not play them? I only wish the volume was higher so I could buy
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Jan 20, 2023 7:49am
RE:RE:Time to cool it.
EVO is doing just fine. Still way undervalued b/c It's not followed as closely as some bigger players. Many investors haven't heard of them. But I'm making money so I can't
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 19, 2023 3:43pm
RE:RE:Article
Thanks for the back handed compliment!
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 19, 2023 1:38pm
RE:RE:RE:RE:Time to cool it.
Couldn't help myself. Bought some back today. I still think we may test the 1 dollar range in the coming days.
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Comment by
Ekenbullets
on Jan 19, 2023 1:37pm
RE:Article
JW is panicking over there. Posting like s crazy man about non-coming news and draws conclusion based on air thinner than nothing. Just visited there first time a few days ago. Not pleasant. He
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Jan 19, 2023 12:48pm
Article
Vertex listed as the first major player but they aren't even using IPSC cells.... https://ericbender.co/2023/01/15/cell-help-for-diabetes/ Let's see how long before this is posted on
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 19, 2023 12:11pm
RE:RE:RE:Time to cool it.
Selling was the right move. Now where to start buying back is the question...
(3)
•••
lightstock
X
View Profile
View Bullboard History
Comment by
lightstock
on Jan 18, 2023 4:50pm
RE:RE:Time to cool it.
I've bought and sold this one a couple times. I don't even like "day-trading" but it's hard not to as the share price swings so much. I bought in again around a dollar, and I
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 18, 2023 12:06pm
RE:Time to cool it.
The shares that I bought in the 80s I'm hoping to sell around 1.50 if the volume is there. I'll hang on to the bulk of my shares for the bigger payout however. Rixy, our
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Jan 18, 2023 11:59am
Time to cool it.
Wellllll, that was a solid return on investment. All those shares bought in the 70's have officially been disposed of. I think the price will cool off as Sernova likely won't put out any news
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 17, 2023 1:20pm
RE:SVA .... On watch
I always say .... Price is King Price action says....this is heading higher Cheers !
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 16, 2023 6:57pm
RE:RE:RE:RE:RE:VCTX210
You are mistaken unless you're talking about preclinical results. That is still a pie in the sky dream for vertex as it is for sernova.
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Comment by
Ekenbullets
on Jan 16, 2023 5:37pm
RE:RE:RE:RE:VCTX210
Vctx210 is with crispr and phase 1 clinical, should have ended in dec. Waiting for some results.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >